Experimental Ebola Vaccine Heads To Human Trials

An experimental Ebola vaccine will soon enter phase one of a clinical trial on humans, the National Institute of Health said Thursday. Initial testing will take place at the NIH’s Clinical Center in Bethesda, Maryland, while the NIH is in the process of working out tests in Ebola-stricken West Africa. The vaccine was developed by the National Institute of Allergy and Infectious Diseases (NIAID) along with top pharmaceutical company GlaxoSmithKline.

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News